Inventor · disambiguated record
Maurizio Mariani
Also filed as: MARIANI MAURIZIO · MARIANI MAURIZIO F · MARIANI MAURIZIO FRANCO
12 granted patents·27 pending applications·57 citations·filing 2012–2025
88Inventor score
Files withADVANCED ACCELERATOR APPLICATIONS SA11NOVARTIS AG9ADVANCED ACCELERATOR APPLICATIONS ITALY SRL7ADVANCED ACCELERATOR APPLICATIONS4ADVANCED ACCELERATOR APPLICATIONS INT S A3
Top patents by PatentIndex Score
39 records- 0194US11904027B2Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS·Filed 2020·Granted Feb 20, 2024·9 cites·26 claims
- 0294US10596276B2Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS ITALY SRL·Filed 2018·Granted Mar 24, 2020·21 cites·24 claims
- 0394US10596278B2Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS ITALY SRL·Filed 2018·Granted Mar 24, 2020·23 cites·25 claims
- 0493US12168063B2Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS SA·Filed 2024·Granted Dec 17, 2024·1 cites·30 claims
- 0593US12161732B2Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS SA·Filed 2024·Granted Dec 10, 2024·1 cites·30 claims
- 0693US12151003B2Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS SA·Filed 2024·Granted Nov 26, 2024·1 cites·30 claims
- 0793US12144873B2Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS SA·Filed 2024·Granted Nov 19, 2024·1 cites·30 claims
- 0890US12491272B2Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS SA·Filed 2024·Granted Dec 9, 2025·0 cites·30 claims
- 0990US12415003B2Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS SA·Filed 2024·Granted Sep 16, 2025·0 cites·30 claims
- 1085US2024075171A1Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS·Filed 2023·Application pending·0 cites
- 1185US2025295820A1Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS SA·Filed 2025·Application pending·0 cites
- 1279US2025213734A1Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS SA·Filed 2025·Application pending·0 cites
- 1369US2025332301A1Stable, concentrated radiopharmaceutical compositionNOVARTIS AG·Filed 2025·Application pending·0 cites
- 1466US2020131224A1Methods for Synthesis of Radionuclide ComplexADVANCED ACCELERATOR APPLICATIONS ITALY S R L·Filed 2019·Application pending·0 cites
- 1565US2021316019A1Methods for Synthesis of Radionuclide ComplexADVANCED ACCELERATOR APPLICATIONS ITALY SRL·Filed 2019·Application pending·0 cites
- 1664US2025025583A1Method of treatment of neuroendocrine tumorsADVANCED ACCELERATOR APPLICATIONS SA·Filed 2024·Application pending·0 cites
- 1764US2022273826A1Prostate specific membrane antigen (psma) ligands and uses thereofNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1863US2022041649A1Methods for Synthesis of Radionuclide ComplexADVANCED ACCELERATOR APPLICATIONS ITALY S R L·Filed 2021·Application pending·0 cites
- 1961US2025009916A1Combination therapy for treating lung cancerNOVARTIS AG·Filed 2022·Application pending·0 cites
- 2061US2021379212A1Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS SA·Filed 2021·Application pending·0 cites
- 2161US2025387523A1Combination therapy of radionuclide complexNOVARTIS AG·Filed 2022·Application pending·0 cites
- 2261US2021379213A1Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS SA·Filed 2021·Application pending·0 cites
- 2360US2022401593A1Stable, concentrated radiopharmaceutical compositionNOVARTIS AG·Filed 2020·Application pending·0 cites
- 2457US2022031872A1Lyophilized Compositions Comprising Rhannexin V-128, Process for Their Preparation and Their Use for Preparing Formulations Containing 99MTc-Rhannexin V-128ADVANCED ACCELERATOR APPLICATIONS INT S A·Filed 2021·Application pending·0 cites
- 2557US2020030465A1Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS ITALY SRL·Filed 2018·Application pending·0 cites
- 2657US2020030466A1Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS ITALY SRL·Filed 2018·Application pending·0 cites
- 2757US2025099634A1Method of treating cancerNOVARTIS AG·Filed 2024·Application pending·0 cites
- 2856US2025269075A1Method of Treating Cancer by Intratumoral Deposition of Radioactive MicroparticlesADVANCED ACCELERATOR APPLICATIONS·Filed 2025·Application pending·0 cites
- 2956US2025161502A1Pharmaceutical compositions comprising a 225-actinium-labelled complex and a bismuth sequestering agentNOVARTIS AG·Filed 2023·Application pending·0 cites
- 3052US2023321287A1Radiolabelled grpr-antagonist for use as theragnosticNOVARTIS AG·Filed 2020·Application pending·0 cites
- 3152US2022378954A1Methods for radiolabelling grpr antagonists and their kitsNOVARTIS AG·Filed 2020·Application pending·0 cites
- 3251US9375498B2Process for the preparation of complexes of 68GaFUGAZZA LORENZA·Filed 2012·Granted Jun 28, 2016·0 cites·17 claims
- 3351US2021346527A1Combination TherapyADVANCED ACCELERATOR APPLICATIONS ITALY SRL·Filed 2019·Application pending·0 cites
- 3450US2023226227A1Prostate specific membrane antigen (psma) ligands and uses thereofADVANCED ACCELERATOR APPLICATIONS ITALY SRL·Filed 2020·Application pending·0 cites
- 3548US9907868B2Process for the preparation of complexes of 68GaADVANCED ACCELERATOR APPLICATIONS S A·Filed 2016·Granted Mar 6, 2018·0 cites·11 claims
- 3648US2022265871A1Method of Treating Cancer by Intratumoral Deposition of Radioactive MicroparticlesADVANCED ACCELERATOR APPLICATIONS·Filed 2020·Application pending·0 cites
- 3745US2022072166A1Method of treatment of neuroendocrine tumorsADVANCED ACCELERATOR APPLICATIONS S A·Filed 2019·Application pending·0 cites
- 3841US10483008B2Process for the purification of Ga-68 from eluate deriving from 68Ge/68Ga generators and chromatographic columns for use in said processADVANCED ACCELERATOR APPLICATIONS INT S A·Filed 2016·Granted Nov 19, 2019·0 cites·2 claims
- 3940US2020038526A1Lyophilized Compositions Comprising Rhannexin V-128, Process for Their Preparation and Their Use for Preparing Formulations Containing 99MTc-Rhannexin V-128ADVANCED ACCELERATOR APPLICATIONS INT S A·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →